Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients
NCT07164326 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-09-10
Summary
Dexmedetomidine nebulization in sever preeclamptic patients
Conditions
- Pressor Response
Interventions
- DRUG
-
Dexmedetomidine
Nebulization of dexmedetomidine
- DRUG
-
Saline
Nebulization of normal saline
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-15
- Primary Completion
- 2026-11-15
- Completion
- 2026-12-15
More Related Trials
-
Use of Preanesthetic Dexmedetomidine in Elderly, Treated-hypertensive Patients
NCT02768610 ·Status: COMPLETED ·Phase: PHASE4
-
Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients
NCT03391609 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Nebulized Dexmedetomidine in Blunting the Effects of Direct Laryngoscopy and Endotracheal Tube on Heart Rate and Blood Pressure.
NCT06103721 ·Status: RECRUITING ·Phase: PHASE4
-
Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.
NCT06327399 ·Status: RECRUITING ·Phase: PHASE2
-
Dexmedetomidine and Agitation After Nasal Surgery
NCT06867302 ·Status: RECRUITING ·Phase: NA
-
Effect of Intratracheal Dexmedetomidine Administration on Recovery From General Anesthesia in Pediatrics Undergoing Lower Abdominal Surgery:
NCT04385602 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Dexmedetomidine on Improving Intubating Conditions Without the Use of Muscle Relaxant
NCT06409377 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine Versus Magnesium Sulfate Infusion in Craniotomy
NCT07199595 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dexmedetomidine in Non-intubated VATS
NCT05863416 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation
NCT01289769 ·Status: COMPLETED ·Phase: PHASE2
-
Dexmedetomidine or Lidocaine for Lessening the Hemodynamic Responses to Laryngoscopy and Intubation
NCT05941767 ·Status: COMPLETED ·Phase: NA
-
Intratracheal Dexmedetomidine Versus Lidocaine in Eye Surgery
NCT05291221 ·Status: COMPLETED ·Phase: NA
-
Cerebral Perfusion Pressure Using Precedex and Other Sedatives
NCT01169467 ·Status: COMPLETED ·Phase: PHASE3
-
Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery
NCT02316236 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine Adjuvant to General Anesthesia of Abdominal Hysterectomy
NCT03600506 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Dexmedetomidine on Microcirculation and Surgical Outcomes After Cardiac Surgeries
NCT02786212 ·Status: COMPLETED ·Phase: NA
-
Effect of Single-dose Dexmedetomidine on Airway Reflex in Adult With Oral Intubation After Thyroidectomy
NCT01774305 ·Status: COMPLETED ·Phase: PHASE4
-
Do Increasing Preoperative Timing of Single Dexmedetomidine Dose Have an Effect on Stress Response of Laryngoscopy and Intubation?
NCT07165483 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Nebulized Dexmedetomidine on Blunting Hemodynamic Changes During Intubation and Pneumoperitoneum in Morbid Obese Patients During Laparoscopic Bariatric Surgery
NCT07054138 ·Status: COMPLETED ·Phase: NA
-
Nebulized Lidocaine, Dexmedetomedine and Their Combination in Direct Laryngoscopy Surgery
NCT04659057 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine on Optic Nerve Sheath Diameter
NCT02753205 ·Status: WITHDRAWN ·Phase: NA
-
Using Dexmedetomidine Prior to Intubation in Neonates
NCT05304598 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery
NCT07080229 ·Status: RECRUITING ·Phase: PHASE3
-
Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study
NCT05909215 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age
NCT01508455 ·Status: COMPLETED ·Phase: PHASE2/PHASE3